Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer

Jeffrey T.R.J. Evans, E. Van Cutsem, M. J. Moore, I. S. Bazin, A. Rosemurgy, G. Bodoky, G. Deplanque, M. Harrison, B. Melichar, D. Pezet, A. Elekes, E. Rock, C. Lin, L. Strauss, P. J. O'Dwyer

Research output: Contribution to journalArticle

25 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences